MedTrace Logo

Heart Rate Variability and Hyperthyroidism: Evaluation of the Short-term Effects of Propanolol

NCT03393728 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2018-01-08

No results posted yet for this study

Summary

Objective: The aim of our study was to evaluate the short term effects of Propanolol on heart rate variability in patients with hyperthyroidism.

Design: In ten patients newly diagnosed as having hyperthyroidism and naïve of all treatment specific for hyperthyroidism, we evaluated the short term effects of Propanolol on heart rate variability (HRV).

Methods: We measured heart rate variability by power spectral analysis during 2 hours of rest and during Ewing's tests before and after the administration of Propanolol 40mg/12 hours orally for 72 hours.

Conditions

  • Hyperthyroidism

Interventions

DRUG

Propanolol

72-hour propanolol before specific treatment of hyperthyroidism

Sponsors & Collaborators

  • Yaounde Central Hospital

    lead OTHER_GOV

Principal Investigators

  • Jean Claude N Mbanya, MD, PhD · Yaounde Central Hospital and University of Yaounde 1

  • Eugène Sobngwi · Hôpital Central de Yaoundé et Université de Yaoundé 1

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-01
Primary Completion
2008-12-30
Completion
2009-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03393728 on ClinicalTrials.gov